SCHEMBL17787181

SCHEMBL17787181

COCc1c(C(=O)OC)cnn1Cc1cnc(Cl)nc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPBWR1 P48145 1/20 0.36
TSHR P16473 1/20 0.36
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.34
RAB9A P51151 1/20 0.34
KLKB1 P03952 1/20 0.34
CYP1A2 P05177 2/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17786853 0.82 F11 (0.40) SMN1; SMN2KLKB1POLBADORA1MAPT
SCHEMBL370914 0.82 NPBWR1 (0.48) LMNANPC1NPBWR1KDM4EADORA1
SCHEMBL17786808 0.81 GRIN1 (0.41) LMNANPC1KMT2AGAARAB9A
SCHEMBL30739173 0.81 NPC1 (0.42) LMNANPC1KMT2ASMN1; SMN2NPBWR1
SCHEMBL30739057 0.81 NPC1 (0.42) LMNANPC1KMT2ASMN1; SMN2NPBWR1
SCHEMBL30739420 0.79 NPC1 (0.40) LMNANPC1KMT2ASMN1; SMN2NPBWR1
SCHEMBL17786902 0.76 KLKB1 (0.47) KLKB1
SCHEMBL30739026 0.76 CACNA1H (0.38) LMNANPC1KMT2ASMN1; SMN2TSHR
SCHEMBL13126531 0.75 KMT2A (0.36) LMNANPC1KMT2ATSHRALDH1A1
SCHEMBL773597 0.74 MAPK14 (0.38) LMNANPC1KMT2ANPBWR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016083816-A1 N-((HETEROARYLMETHYL)-HETEROARYL-CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2016-06-02 WO disclosed